![]() |
Volumn 22, Issue 4, 2012, Pages 214-215
|
Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BRAIN DERIVED NEUROTROPHIC FACTOR;
CITALOPRAM;
FLUOXETINE;
FLUVOXAMINE;
METHIONINE;
PAROXETINE;
SERTRALINE;
VALINE;
VENLAFAXINE;
ADULT;
AMINO ACID SUBSTITUTION;
ARTICLE;
CHINESE;
CLINICAL GLOBAL IMPRESSION SCALE;
DISEASE SEVERITY;
DRUG RESPONSE;
EXON;
FEMALE;
GENETIC ASSOCIATION;
GENETIC LINKAGE;
HAMILTON SCALE;
HARDY WEINBERG DISTRIBUTION LAW;
HETEROZYGOTE;
HUMAN;
MAJOR CLINICAL STUDY;
MAJOR DEPRESSION;
MALE;
PHARMACOGENETICS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PSYCHOPHARMACOTHERAPY;
SINGLE NUCLEOTIDE POLYMORPHISM;
TREATMENT OUTCOME;
ADULT;
AMINO ACID SUBSTITUTION;
ANTIDEPRESSIVE AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
BRAIN-DERIVED NEUROTROPHIC FACTOR;
CHINA;
DEPRESSIVE DISORDER, MAJOR;
ETHNIC GROUPS;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
GENETICS, POPULATION;
HUMANS;
MALE;
POLYMORPHISM, SINGLE NUCLEOTIDE;
TREATMENT OUTCOME;
|
EID: 84863422630
PISSN: 09558829
EISSN: 14735873
Source Type: Journal
DOI: 10.1097/YPG.0b013e32834c0c87 Document Type: Article |
Times cited : (19)
|
References (5)
|